(Q40222489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

title

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

author name string

Goodman AD

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

Cohen JA

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

Vollmer T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

Rizzo M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

Cohen R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

Marinucci L

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

Blight AR

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

publication date

29 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

30 August 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

page(s)

357-368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury

30 August 2019

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

Effects of 4-aminopyridine in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

Poisoning with 4-Aminopyridine: Report of Three Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

4-Aminopyridine in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

Clinical outcome measures for research in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506069538

21 January 2018

Identifiers

DOI

10.1177/1352458506069538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17439905%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

1 reference